



Next-generation targeting in Immunooncology: A British Land x Nucleate Breakfast Series
Immuno-oncology Breakfast
Nucleate UK and British Land are collaborating on a new breakfast series spotlighting breakthrough research and ventures emerging from London and UK universities. Each session will explore a key theme in science and innovation. This will delve into next-gen targeting & multi-specifics in immunooncology.
This series is designed to foster cross-disciplinary dialogue and highlight the UK’s most promising scientific spinouts and early-stage ventures.
Event Schedule: 30th September 2025
08:30 - 09:00: Arrival
09:00 - 09:15: Introduction and flash talks (Jonathan Kwok - CEO & Cofounder Infinitopes and Vincent Muczynski - Director of Biology at NovalGen)
09:15 - 09:50: Fireside Chat (Raj Mehta - CEO & Cofounder Adrendra Therapeutics
09:50 - 10:30: Networking with breakfast
British Land and Nucleate will be taking photography and videography at the event for marketing purposes. As a result, your image may be recorded and made publicly available in British Land and Nucleate promotional material. You have the right to object to this. Please make yourself known to the photographer and videographer at the event.
